前往化源商城

5437-33-2 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:24386 靶标:N/A
External ID: Sarm1 TIR NADase inhibitors
Protocol: Sarm1 "Sam-Tir" (Sarm1 without N-terminus, including residues 410-721 of human Sarm1 protein) was expressed in NRK1-HEK/293T cells by transient transfection: 15 million cells were transfected with 15microg plasmid DNA (Kow et al., 2018. Current Biology, 28:421), supplementing with 1mM nicotinamide riboside (NR). After 48 hours, cells were harvested and lysed. Reaction mixtures were prepared by mixing SARM1 SAM-TIR cell lysate (0.13 microg total protein), compound stock (5 microM final concentration, NCI diversity IV), and PBS (pH 7.4) to a final volume of 12 microl. NAD (5 microM final concentration) was then added for a final reaction volume of 20 microl. The reaction was incubated at 37 degrees C for 60 min, and then stopped by addition of 180 microl of 0.55 M perchloric acid (HClO4) and placed on ice. After 10 min on ice, the reaction plates were centrifuged for 10 min at 4,000 rpm (Sorvall ST 16R centrifuge). The supernatant (120 microl) was transferred to a new plate and 10 microl of 3M K2CO3 was added to neutralize the solution. Precipitated salts were removed by centrifugation 10 min at 4,000 rpm (Sorvall ST 16R centrifuge). The supernatant was transferred and analyzed by HPLC (Shimadzu Nexera X2) to quantify the amounts of NAD and the enzymatically cleaved product ADPR in each sample. From these values, the NAD/ADPR ratio was calculated for each compound as a measure of NAD cleavage activity (Note: there is a residual but detectable ADPR in control samples). This ratio was compared to the ratio generated in the absence of compound inhibitors. A reduction of NADase activity (NAD/ADPR ratio > 4) was used to identify compounds that inhibited the SAM-TIR catalyzed NAD cleavage.
Comment: The ratio of NAD/ADPR at time 0 is 15-16. The compounds are listed with their NSC numbers.
NAD/ADPR
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Staphylococcus aureus
External ID: CHEMBL4296192
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL352
ChEMBL Target Name: Staphylococcus aureus
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
Standard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
Inhibition=-17.94%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=3.08%Average; N=2; Conc=25 Um ;
Inhibition=5.03%Average; N=2; Conc=25 Um ;
Inhibition=-8.85%Average; N=2; Conc=25 Um ;
Inhibition=3.06%Average; N=2; Conc=25 Um ;
Inhibition=3.85%Average; N=2; Conc=25 Um ;
Inhibition=9.16%Average; N=2; Conc=25 Um ;
Inhibition=9.46%Average; N=2; Conc=25 Um ;
Inhibition=-2.99%Average; N=2; Conc=25 Um ;
Inhibition=15.05%Average; N=2; Conc=25 Um ;
Inhibition=11.42%Average; N=2; Conc=25 Um ;
Inhibition=34.7%Average; N=2; Conc=25 Um ;
Inhibition=22.17%Average; N=2; Conc=25 Um ;
Inhibition=11.51%Average; N=2; Conc=25 Um ;
Inhibition=18.39%Average; N=2; Conc=25 Um ;
Inhibition=-2.4%Average; N=2; Conc=25 Um ;
Inhibition=-2.47%Average; N=2; Conc=25 Um ;
Inhibition=11.14%Average; N=2; Conc=25 Um ;
Inhibition=-9.71%Average; N=2; Conc=25 Um ;
Inhibition=8.93%Average; N=2; Conc=25 Um ;
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Escherichia coli
External ID: CHEMBL4296783
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL354
ChEMBL Target Name: Escherichia coli
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
Standard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
Inhibition=15.41%Average; N=2; Conc=25 Um ;
Inhibition=14.7%Average; N=2; Conc=25 Um ;
Inhibition=0.06%Average; N=2; Conc=25 Um ;
Inhibition=2.47%Average; N=2; Conc=25 Um ;
Inhibition=1.82%Average; N=2; Conc=25 Um ;
Inhibition=-14.74%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=17.18%Average; N=2; Conc=25 Um ;
Inhibition=9.97%Average; N=2; Conc=25 Um ;
Inhibition=9.66%Average; N=2; Conc=25 Um ;
Inhibition=-16.8%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=7%Average; N=2; Conc=25 Um ;
Inhibition=1.25%Average; N=2; Conc=25 Um ;
Inhibition=3%Average; N=2; Conc=25 Um ;
Inhibition=9.13%Average; N=2; Conc=25 Um ;
Inhibition=-1.34%Average; N=2; Conc=25 Um ;
Inhibition=11.66%Average; N=2; Conc=25 Um ;
Inhibition=-5.6%Average; N=2; Conc=25 Um ;
Inhibition=2.79%Average; N=2; Conc=25 Um ;
Inhibition=10.6%Average; N=2; Conc=25 Um ;
Inhibition=0.28%Average; N=2; Conc=25 Um ;
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Acinetobacter baumannii
External ID: CHEMBL4296193
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL614425
ChEMBL Target Name: Acinetobacter baumannii
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
Standard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
Inhibition=-6.11%Average; N=2; Conc=25 Um ;
Inhibition=-6.09%Average; N=2; Conc=25 Um ;
Inhibition=-12.8%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=7.42%Average; N=2; Conc=25 Um ;
Inhibition=1.42%Average; N=2; Conc=25 Um ;
Inhibition=0.76%Average; N=2; Conc=25 Um ;
Inhibition=-5.59%Average; N=2; Conc=25 Um ;
Inhibition=-0.94%Average; N=2; Conc=25 Um ;
Inhibition=11.99%Average; N=2; Conc=25 Um ;
Inhibition=4.29%Average; N=2; Conc=25 Um ;
Inhibition=-13%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=-5.64%Average; N=2; Conc=25 Um ;
Inhibition=-9.14%Average; N=2; Conc=25 Um ;
Inhibition=-10.79%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=-8.06%Average; N=2; Conc=25 Um ;
Inhibition=-6.56%Average; N=2; Conc=25 Um ;
Inhibition=-10.04%Average; N=2; Conc=25 Um ;Outside typical range
Inhibition=-4.97%Average; N=2; Conc=25 Um ;
Inhibition=0.08%Average; N=2; Conc=25 Um ;
Inhibition=4.53%Average; N=2; Conc=25 Um ;
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Pseudomonas aeruginosa
External ID: CHEMBL4296187
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Target ChEMBL ID: CHEMBL348
ChEMBL Target Name: Pseudomonas aeruginosa
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
Inhibition=10.84%Average; N=1
Inhibition=14.55%Average; N=1
Inhibition=-13.46%Average; N=1Outside typical range
Inhibition=21.47%Average; N=2
Inhibition=32.07%Average; N=1
Inhibition=2.27%Average; N=1
Inhibition=-21.74%Average; N=1Outside typical range
Inhibition=9.41%Average; N=1
Inhibition=19.34%Average; N=1
Inhibition=-25.08%Average; N=1Outside typical range
Inhibition=9.21%Average; N=4
Inhibition=15.98%Average; N=4
Inhibition=8.03%Average; N=1
Inhibition=-1.26%Average; N=1
Inhibition=6.81%Average; N=1
Inhibition=-8.48%Average; N=1
Inhibition=25.25%Average; N=1
Inhibition=44.67%Average; N=1
Inhibition=1.69%Average; N=1
Inhibition=2.93%Average; N=1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Cryptococcus neoformans
External ID: CHEMBL4296190
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Target ChEMBL ID: CHEMBL365
ChEMBL Target Name: Cryptococcus neoformans
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10MIC>10000nMMedian N= 2; Maxinhib 9.6 Pct
Inhibition=-7.36%Average; N=2; Conc=25 Um ;
20MIC>20000nMMedian N= 2; Maxinhib 17.1 Pct
10MIC>10000nMMedian N= 2; Maxinhib 6.5 Pct
Inhibition=-5.61%Average; N=2
10MIC>10000nMMedian N= 2; Maxinhib 7.2 Pct
Inhibition=-0.18%Average; N=2
Inhibition=-8.54%Average; N=2
Inhibition=-5.03%Average; N=2
Inhibition=-1.5%Average; N=2
20MIC>20000nMMedian N= 2; Maxinhib 8.8 Pct
0.1563MIC=156.3nMMedian N= 2
Inhibition=-9.6%Average; N=2; Conc=25 Um ;
Inhibition=-0.09%Average; N=2
Inhibition=-3.07%Average; N=2
Inhibition=-2.97%Average; N=2
20MIC>20000nMMedian N= 2; Maxinhib 9.3 Pct
Inhibition=-12.66%Average; N=2; Conc=25 Um ;Outside typical range
10MIC>10000nMMedian N= 2; Maxinhib 4.5 Pct
20MIC>20000nMMedian N= 2; Maxinhib 9.3 Pct
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:11908 靶标:N/A
External ID: RMI-FANCM-MM2
Protocol: FP HTS. Screening took place at the University of Wisconsin Small Molecule Screening and Synthesis Facility. A master mix of RMI core complex and F-MM2 (30 microL per well) was plated in black 384 shallow well plates (ThermoFisher, Waltham, MA), using a BioTek "MicroFlo Select" reagent dispenser. Compounds were added using a Beckman FX liquid handler; 0.33 microL of 10 mM stock was added for a final compound concentration of 33 microM. MM2 and cMM2 were each added to 4 wells of master mix per plate to a final concentration of 10 muM to serve as controls. Following compound addition, plates were covered, centrifuged briefly, and incubated for 20 minutes at room temperature. FP measurements were taking using a Tecan "Safire 2" microplate reader. Instrument settings were as follows: top read, EX 470, EM 525/20, G-factor 0.89947. A suitable gain was calculated from the first plate of each day. Z' scores for were calculated for each plate; plates with Z' scores <0.5 were rerun prior to analysis.
Comment:
Concentration uMData readout
3355
3363
3365
3363
3361
3362
3361
3358
3371
3361
3364
3383
33158
3384
33104
3360
3362
3359
3358
3359
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Candida albicans
External ID: CHEMBL4296189
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Target ChEMBL ID: CHEMBL366
ChEMBL Target Name: Candida albicans
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10MIC>10000nMMedian N= 2; Maxinhib 3.0 Pct
Inhibition=8.04%Average; N=2; Conc=25 Um ;
20MIC>20000nMMedian N= 2; Maxinhib 7.4 Pct
10MIC>10000nMMedian N= 2; Maxinhib 4.8 Pct
Inhibition=3.92%Average; N=2
10MIC>10000nMMedian N= 2; Maxinhib 10.4 Pct
Inhibition=-0.23%Average; N=2
Inhibition=0.3%Average; N=2
Inhibition=-0.48%Average; N=2
Inhibition=2.62%Average; N=2
20MIC>20000nMMedian N= 2; Maxinhib 8.0 Pct
0.0781MIC<=78.1nMMedian N= 2
Inhibition=-3.39%Average; N=2; Conc=25 Um ;
Inhibition=5.22%Average; N=2
Inhibition=3.37%Average; N=2
Inhibition=4.56%Average; N=2
20MIC>20000nMMedian N= 2; Maxinhib 3.4 Pct
Inhibition=-0.73%Average; N=2; Conc=25 Um ;
10MIC>10000nMMedian N= 2; Maxinhib 7.9 Pct
20MIC>20000nMMedian N= 2; Maxinhib 1.4 Pct
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:DTP/NCI 靶标:N/A
External ID: MCF7_OneDose
Protocol: NCI-60 Human Tumor Cell Lines Screen was performed using the standard one-dose NCI protocol, which is described in more detail at https://dtp.cancer.gov/discovery_development/nci-60/default.htm.

Compounds with GIPRCNT values below 10 were considered active. Activity score was based on GIPRCNT using the following formula:
max(-GIPRCNT/2 + 50, 0)
Score is 0 for GIPRCNT values of 100 or above, 50 for GIPRCNT values of 0, and 100 for GIPRCNT values of -100.
Comment: These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI National Service Center (NSC) number, which is contained in the
PUBCHEM_EXT_DATASOURCE_REGID field. In the NCI cell line identification system, MCF7 is panel number 5, cell number 1. PANELCODE or PANELNAME identify the NCI-60 cell panel. PANELNBR does NOT identify the NCI-60 panel.

EXPID is the NCI internal tracking number for the experiment identifier, and PREFIX = 'S' for the NSCs submitted through the NCI Chemical Agents repository.

Substance concentration unit is indicated in the data table, using the following abbreviations: M = molar (M), u = micrograms/milliliter (microg/mL), V = volumetric fraction.

M_GIPRCNT represents the mean growth percent for that experiment, and N_GIPRCNT indicates the number of values for that NSC within an experiment, while STDEV_GIPRCNT is the standard deviation. Most NSCs are tested once per experiment, resulting in EXP_COUNT = 1.
EXPIDPREFIXCONCENTRATION_UNITCONCENTRATIONPANELNBRCELLNBRPANELNAMECELLNAMEPANELCODEM_GIPRCNTN_GIPRCNTSTDDEV_GIPRCNTEXP_COUNT
2106OS49SM1.0E-551Breast CancerMCF7BRE88.231101
2106OS49SM1.0E-551Breast CancerMCF7BRE87.1119101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.4371101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.7113101
2106OS49SM1.0E-551Breast CancerMCF7BRE97.2463101
2106OS49SM1.0E-551Breast CancerMCF7BRE90.0129101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.7031101
2106OS49SM1.0E-551Breast CancerMCF7BRE30.8539101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.2896101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.8526101
2106OS49SM1.0E-551Breast CancerMCF7BRE83.1036101
2106OS49SM1.0E-551Breast CancerMCF7BRE84.2194101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.3237101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.6034101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.6643101
2106OS52SM1.0E-551Breast CancerMCF7BRE91.2503101
2106OS52SM1.0E-551Breast CancerMCF7BRE94.8714101
2106OS52SM1.0E-551Breast CancerMCF7BRE93.7372101
2106OS52SM1.0E-551Breast CancerMCF7BRE112.6132101
2106OS52SM1.0E-551Breast CancerMCF7BRE73.375101
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:Center for Chemical Genomics, University of Michigan 靶标:
External ID: MScreen:TargetID_600
Protocol: C-terminally 6xHis tagged CDK2/Cyclin A complex and N-terminally Flag tagged CDC25B C473S (372-566) were expressed and purified. Proteins were incubated together at a final concentration of 125 nM each for 1 hr prior to incubation with compound for 1 hr, followed by addition of anti-6xHis europium cryptate donor beads (Cisbio) and anti-Flag XL-665 acceptor beads (Cisbio) at a final dilution of 1:350 for 1 hr. 20mM potassium fluoride was added 10 minute prior to plate reading. Assay reagents were dispensed using a multidrop liquid dispenser (Thermo Scientific) onto uncoated, black, low-volume, 384-well plates (Corning). Assay plates were quantified using an Envision plate reader (Perkin-Elmer) with excitation of the europium crytate donor at 337 nm wavelength and emission of the donor at 620 nm and emission of the XL-665 acceptor at 665 nm in 18 uL volumes. Assays were performed in a buffer containing 50 mM Tris (pH 7.5), 50 mM NaCl, 10mM MgCl2, 1mM TCEP, with addition of and 1mM ATP, 0.05% BSA, and 0.05% Tween-20 immediately prior to the start of the assay.
Comment: The activity outcome is based on a Z-score (number of standard deviations from the negative control mean) of 3 or higher on at least 50% times that the sample was screened.
For instance, if the sample was screened in n=4 runs, it would be considered active only if it had a Z-score of 3 or above in at least 2 runs.

This screen was funded by NIH grant number: R01CA181185
Z_SCORE
0.28
-0.54
-0.02
0.22
0.37
-0.81
-0.26
-0.14
-0.61
-0.44
0.29
0.22
-0.12
-0.13
0.95
-0.29
-0.37
0.17
-0.64
-0.78
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Klebsiella pneumoniae
External ID: CHEMBL4296186
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Target ChEMBL ID: CHEMBL350
ChEMBL Target Name: Klebsiella pneumoniae
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: CO-ADD Antimicrobial Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
Inhibition=0.93%Average; N=2
Inhibition=16.87%Average; N=4
Inhibition=14.36%Average; N=4
Inhibition=8.63%Average; N=2
Inhibition=22.77%Average; N=2
MIC>32ug.mL-1Median N= 2; Maxinhib 12.7 Pct
Inhibition=-22.42%Average; N=2Outside typical range
Inhibition=0.23%Average; N=4
MIC>32ug.mL-1Median N= 2; Maxinhib 20.1 Pct
Inhibition=10.23%Average; N=4
Inhibition=3.15%Average; N=4
Inhibition=7.81%Average; N=4
Inhibition=-10.52%Average; N=4Outside typical range
MIC>32ug.mL-1Median N= 2; Maxinhib 19.8 Pct
Inhibition=7.19%Average; N=4
Inhibition=6.16%Average; N=2
Inhibition=11.98%Average; N=4
Inhibition=3.45%Average; N=2
Inhibition=3.96%Average; N=2
Inhibition=4.88%Average; N=2